Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Participation | 59 | 2024 | 1447 | 7.910 |
Why?
|
Decision Making | 73 | 2024 | 3955 | 6.860 |
Why?
|
Decision Support Techniques | 46 | 2024 | 2004 | 5.700 |
Why?
|
Osteoarthritis, Hip | 9 | 2022 | 408 | 3.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 27 | 2024 | 4055 | 2.310 |
Why?
|
Patient Education as Topic | 22 | 2024 | 2331 | 2.140 |
Why?
|
Osteoarthritis, Knee | 9 | 2022 | 1247 | 2.110 |
Why?
|
Physician-Patient Relations | 14 | 2024 | 3270 | 1.800 |
Why?
|
Patient Preference | 16 | 2024 | 947 | 1.720 |
Why?
|
Mastectomy | 16 | 2022 | 1848 | 1.690 |
Why?
|
Breast Neoplasms | 43 | 2024 | 21069 | 1.670 |
Why?
|
Patient Satisfaction | 16 | 2024 | 3477 | 1.650 |
Why?
|
Psychometrics | 13 | 2021 | 3061 | 1.600 |
Why?
|
Patient-Centered Care | 11 | 2021 | 1447 | 1.490 |
Why?
|
Spinal Stenosis | 5 | 2020 | 259 | 1.310 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6958 | 1.260 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2022 | 1414 | 1.070 |
Why?
|
Arthroplasty, Replacement, Knee | 4 | 2022 | 1378 | 1.060 |
Why?
|
Early Detection of Cancer | 15 | 2024 | 3238 | 1.060 |
Why?
|
Multicenter Studies as Topic | 3 | 2024 | 1729 | 0.930 |
Why?
|
Communication | 11 | 2024 | 3908 | 0.910 |
Why?
|
Informed Consent | 7 | 2019 | 1010 | 0.820 |
Why?
|
Orthopedic Procedures | 2 | 2021 | 1279 | 0.730 |
Why?
|
Genetic Counseling | 2 | 2024 | 634 | 0.710 |
Why?
|
Quality Assurance, Health Care | 4 | 2016 | 2170 | 0.700 |
Why?
|
Tracheostomy | 1 | 2024 | 430 | 0.700 |
Why?
|
Mammaplasty | 5 | 2022 | 1264 | 0.680 |
Why?
|
Knowledge | 1 | 2021 | 178 | 0.670 |
Why?
|
Orthopedics | 2 | 2018 | 901 | 0.640 |
Why?
|
Choice Behavior | 9 | 2024 | 846 | 0.620 |
Why?
|
Caregivers | 4 | 2024 | 2304 | 0.590 |
Why?
|
Reproducibility of Results | 17 | 2023 | 20133 | 0.590 |
Why?
|
Goals | 4 | 2011 | 717 | 0.580 |
Why?
|
Humans | 139 | 2024 | 765926 | 0.580 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3719 | 0.570 |
Why?
|
Cross-Sectional Studies | 25 | 2024 | 26282 | 0.560 |
Why?
|
Quality of Health Care | 10 | 2018 | 4305 | 0.500 |
Why?
|
Referral and Consultation | 6 | 2021 | 3615 | 0.500 |
Why?
|
Female | 86 | 2024 | 396141 | 0.480 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2022 | 0.460 |
Why?
|
Middle Aged | 57 | 2024 | 223016 | 0.450 |
Why?
|
Health Care Surveys | 6 | 2017 | 2426 | 0.450 |
Why?
|
Aged | 44 | 2024 | 171163 | 0.450 |
Why?
|
Patients | 3 | 2016 | 908 | 0.450 |
Why?
|
Checklist | 2 | 2018 | 837 | 0.440 |
Why?
|
Physicians | 5 | 2023 | 4591 | 0.430 |
Why?
|
Quality Indicators, Health Care | 2 | 2021 | 1804 | 0.430 |
Why?
|
Depression | 3 | 2022 | 8223 | 0.400 |
Why?
|
Coronary Angiography | 3 | 2018 | 4498 | 0.400 |
Why?
|
Lumbar Vertebrae | 4 | 2018 | 1878 | 0.400 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10380 | 0.400 |
Why?
|
Quality Improvement | 2 | 2017 | 3847 | 0.390 |
Why?
|
Directive Counseling | 2 | 2015 | 171 | 0.390 |
Why?
|
Genetic Testing | 3 | 2024 | 3594 | 0.390 |
Why?
|
Health Services Research | 3 | 2015 | 1811 | 0.380 |
Why?
|
Quality of Life | 12 | 2022 | 13463 | 0.370 |
Why?
|
Diskectomy | 1 | 2012 | 203 | 0.350 |
Why?
|
Attitude of Health Personnel | 5 | 2017 | 3928 | 0.350 |
Why?
|
Professional-Patient Relations | 2 | 2008 | 723 | 0.350 |
Why?
|
Radial Artery | 1 | 2012 | 187 | 0.350 |
Why?
|
Emotions | 3 | 2020 | 2759 | 0.350 |
Why?
|
Survivors | 3 | 2012 | 2373 | 0.340 |
Why?
|
Arthroplasty, Replacement | 1 | 2013 | 312 | 0.330 |
Why?
|
Mastectomy, Segmental | 4 | 2017 | 964 | 0.330 |
Why?
|
Focus Groups | 4 | 2024 | 1458 | 0.330 |
Why?
|
Catheterization, Peripheral | 1 | 2012 | 345 | 0.300 |
Why?
|
Internal Medicine | 1 | 2016 | 1064 | 0.300 |
Why?
|
Angina Pectoris | 1 | 2012 | 957 | 0.300 |
Why?
|
Male | 43 | 2024 | 363815 | 0.290 |
Why?
|
Femoral Artery | 1 | 2012 | 825 | 0.290 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 622 | 0.280 |
Why?
|
Emergency Medicine | 1 | 2016 | 1222 | 0.280 |
Why?
|
Advance Directives | 1 | 2009 | 249 | 0.280 |
Why?
|
Estrogen Replacement Therapy | 1 | 2014 | 1206 | 0.280 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4904 | 0.280 |
Why?
|
Health Literacy | 3 | 2024 | 465 | 0.280 |
Why?
|
Adult | 40 | 2024 | 223088 | 0.280 |
Why?
|
Cooperative Behavior | 3 | 2016 | 1512 | 0.270 |
Why?
|
Pilot Projects | 9 | 2024 | 8724 | 0.270 |
Why?
|
Primary Health Care | 5 | 2024 | 4736 | 0.260 |
Why?
|
Menopause | 1 | 2014 | 1659 | 0.250 |
Why?
|
Colonoscopy | 2 | 2024 | 1408 | 0.250 |
Why?
|
Perception | 4 | 2024 | 1204 | 0.240 |
Why?
|
Data Collection | 4 | 2023 | 3318 | 0.240 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7871 | 0.240 |
Why?
|
Socioeconomic Factors | 6 | 2018 | 7842 | 0.230 |
Why?
|
Time Factors | 4 | 2024 | 40097 | 0.230 |
Why?
|
Maine | 1 | 2024 | 146 | 0.230 |
Why?
|
United States | 18 | 2024 | 72909 | 0.220 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 713 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3230 | 0.220 |
Why?
|
Aged, 80 and over | 11 | 2024 | 59496 | 0.220 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2419 | 0.210 |
Why?
|
Qualitative Research | 3 | 2024 | 3136 | 0.210 |
Why?
|
Neoplasms | 6 | 2023 | 22340 | 0.210 |
Why?
|
Cardiology | 1 | 2014 | 1696 | 0.210 |
Why?
|
Decision Theory | 2 | 2015 | 27 | 0.210 |
Why?
|
Mass Screening | 5 | 2024 | 5449 | 0.200 |
Why?
|
Academic Medical Centers | 4 | 2023 | 2782 | 0.200 |
Why?
|
Massachusetts | 4 | 2024 | 8882 | 0.200 |
Why?
|
Information Dissemination | 1 | 2011 | 1142 | 0.200 |
Why?
|
Pamphlets | 2 | 2014 | 71 | 0.200 |
Why?
|
Curriculum | 1 | 2016 | 3784 | 0.200 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2024 | 637 | 0.200 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5364 | 0.190 |
Why?
|
Neoplasm Metastasis | 2 | 2009 | 4882 | 0.190 |
Why?
|
Video Recording | 2 | 2019 | 977 | 0.190 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2024 | 1563 | 0.190 |
Why?
|
Research Design | 2 | 2015 | 6204 | 0.190 |
Why?
|
Program Development | 3 | 2016 | 1297 | 0.190 |
Why?
|
Occult Blood | 1 | 2022 | 199 | 0.190 |
Why?
|
Surgical Procedures, Operative | 1 | 2013 | 1930 | 0.190 |
Why?
|
Algorithms | 2 | 2020 | 14064 | 0.190 |
Why?
|
Delphi Technique | 3 | 2018 | 893 | 0.190 |
Why?
|
Chemotherapy, Adjuvant | 7 | 2022 | 3542 | 0.180 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.180 |
Why?
|
Pediatrics | 1 | 2016 | 3609 | 0.180 |
Why?
|
Osteoarthritis | 2 | 2018 | 1050 | 0.170 |
Why?
|
Chemoprevention | 1 | 2002 | 327 | 0.170 |
Why?
|
Clinical Competence | 1 | 2016 | 4855 | 0.170 |
Why?
|
Independent Living | 1 | 2024 | 583 | 0.170 |
Why?
|
Anxiety | 4 | 2024 | 4669 | 0.170 |
Why?
|
Interviews as Topic | 4 | 2024 | 2740 | 0.170 |
Why?
|
Intention | 1 | 2022 | 346 | 0.160 |
Why?
|
Disclosure | 2 | 2024 | 756 | 0.160 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2185 | 0.160 |
Why?
|
Electronics | 1 | 2020 | 314 | 0.160 |
Why?
|
California | 2 | 2014 | 1435 | 0.160 |
Why?
|
Feasibility Studies | 4 | 2012 | 5300 | 0.160 |
Why?
|
Esthetics | 2 | 2010 | 327 | 0.150 |
Why?
|
Social Support | 2 | 2024 | 2190 | 0.150 |
Why?
|
Videotape Recording | 2 | 2011 | 333 | 0.150 |
Why?
|
Home Care Services | 1 | 2024 | 658 | 0.150 |
Why?
|
Prospective Studies | 9 | 2024 | 54807 | 0.150 |
Why?
|
Opioid-Related Disorders | 2 | 2024 | 2177 | 0.140 |
Why?
|
Patient Care Planning | 1 | 2002 | 903 | 0.130 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14745 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3249 | 0.130 |
Why?
|
Health Policy | 2 | 2011 | 2699 | 0.130 |
Why?
|
Confidence Intervals | 3 | 2010 | 2915 | 0.130 |
Why?
|
Utilization Review | 1 | 2017 | 381 | 0.130 |
Why?
|
Trust | 1 | 2020 | 532 | 0.130 |
Why?
|
Hip Fractures | 1 | 2024 | 995 | 0.130 |
Why?
|
Patient Care Team | 2 | 2017 | 2515 | 0.120 |
Why?
|
Consumer Health Information | 1 | 2018 | 215 | 0.120 |
Why?
|
Expert Testimony | 1 | 2017 | 266 | 0.120 |
Why?
|
Program Evaluation | 2 | 2016 | 2502 | 0.120 |
Why?
|
Aortic Valve | 1 | 2024 | 1964 | 0.120 |
Why?
|
Primary Prevention | 1 | 2002 | 1187 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 575 | 0.120 |
Why?
|
Leiomyoma | 2 | 2009 | 644 | 0.120 |
Why?
|
Body Image | 1 | 2019 | 645 | 0.120 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15645 | 0.110 |
Why?
|
Educational Status | 3 | 2010 | 2510 | 0.110 |
Why?
|
Politics | 1 | 2021 | 821 | 0.110 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1607 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 561 | 0.110 |
Why?
|
Educational Measurement | 3 | 2010 | 1260 | 0.110 |
Why?
|
Research Subjects | 1 | 2015 | 248 | 0.100 |
Why?
|
Fear | 2 | 2019 | 1496 | 0.100 |
Why?
|
Sweating | 1 | 2014 | 155 | 0.100 |
Why?
|
Social Class | 2 | 2020 | 2007 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8721 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2040 | 0.100 |
Why?
|
Risk Assessment | 9 | 2024 | 24275 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1666 | 0.100 |
Why?
|
Down Syndrome | 1 | 2020 | 915 | 0.100 |
Why?
|
Child | 4 | 2024 | 80568 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2530 | 0.090 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11090 | 0.090 |
Why?
|
Hospitals, General | 1 | 2016 | 803 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3460 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2024 | 65194 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1497 | 0.090 |
Why?
|
Medicare | 2 | 2024 | 6815 | 0.090 |
Why?
|
Health Personnel | 4 | 2023 | 3385 | 0.090 |
Why?
|
San Francisco | 1 | 2011 | 165 | 0.090 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2024 | 81537 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11196 | 0.090 |
Why?
|
Health Status | 2 | 2021 | 4085 | 0.090 |
Why?
|
Cohort Studies | 4 | 2019 | 41680 | 0.090 |
Why?
|
Observation | 1 | 2012 | 309 | 0.090 |
Why?
|
Random Allocation | 1 | 2014 | 2394 | 0.080 |
Why?
|
Social Values | 2 | 2011 | 224 | 0.080 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 228 | 0.080 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1308 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2741 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2017 | 1029 | 0.080 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7423 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4527 | 0.080 |
Why?
|
Mammography | 1 | 2019 | 2424 | 0.080 |
Why?
|
Insurance Claim Review | 1 | 2013 | 744 | 0.080 |
Why?
|
Attitude to Health | 1 | 2017 | 2020 | 0.070 |
Why?
|
Health Plan Implementation | 1 | 2011 | 337 | 0.070 |
Why?
|
Logistic Models | 3 | 2011 | 13273 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2077 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13446 | 0.070 |
Why?
|
Tumor Burden | 3 | 2017 | 1888 | 0.070 |
Why?
|
Education | 1 | 2008 | 531 | 0.060 |
Why?
|
Cognition | 1 | 2023 | 7043 | 0.060 |
Why?
|
Internationality | 1 | 2011 | 1007 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11858 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2046 | 0.060 |
Why?
|
Internal-External Control | 1 | 2006 | 348 | 0.060 |
Why?
|
Tape Recording | 1 | 2024 | 78 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2008 | 514 | 0.060 |
Why?
|
Internet | 3 | 2017 | 3106 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3430 | 0.060 |
Why?
|
Uncertainty | 2 | 2024 | 763 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2188 | 0.060 |
Why?
|
Quality Control | 1 | 2006 | 835 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9373 | 0.050 |
Why?
|
Control Groups | 1 | 2023 | 106 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2688 | 0.050 |
Why?
|
Community Health Services | 1 | 2008 | 657 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2017 | 878 | 0.050 |
Why?
|
Community Health Centers | 1 | 2006 | 469 | 0.050 |
Why?
|
Needs Assessment | 1 | 2008 | 1140 | 0.050 |
Why?
|
Germany | 1 | 2024 | 882 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10046 | 0.050 |
Why?
|
Denmark | 1 | 2024 | 774 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3407 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4058 | 0.050 |
Why?
|
Health Care Reform | 1 | 2011 | 1257 | 0.050 |
Why?
|
Child, Preschool | 1 | 2024 | 42510 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 18074 | 0.050 |
Why?
|
Sweden | 1 | 2024 | 1381 | 0.050 |
Why?
|
Odds Ratio | 2 | 2010 | 9656 | 0.050 |
Why?
|
Genes, BRCA2 | 2 | 2015 | 591 | 0.050 |
Why?
|
Comprehension | 1 | 2006 | 636 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2011 | 997 | 0.050 |
Why?
|
Australia | 1 | 2024 | 1260 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2024 | 441 | 0.040 |
Why?
|
Genes, BRCA1 | 2 | 2015 | 753 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12059 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4863 | 0.040 |
Why?
|
Risk Factors | 6 | 2022 | 74850 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2277 | 0.040 |
Why?
|
Certification | 2 | 2017 | 420 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2017 | 4805 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2120 | 0.040 |
Why?
|
Reproduction | 1 | 2023 | 645 | 0.040 |
Why?
|
Communication Barriers | 1 | 2002 | 418 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2021 | 305 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6544 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39228 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 993 | 0.040 |
Why?
|
Terminal Care | 1 | 2009 | 1769 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 921 | 0.030 |
Why?
|
Benchmarking | 1 | 2003 | 1055 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2020 | 641 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5945 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1752 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2003 | 1086 | 0.030 |
Why?
|
Social Stigma | 1 | 2021 | 787 | 0.030 |
Why?
|
Risk | 2 | 2021 | 9599 | 0.030 |
Why?
|
General Surgery | 2 | 2010 | 1722 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2015 | 2885 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2022 | 1535 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2844 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5088 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9443 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2004 | 2895 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2018 | 1435 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2019 | 2111 | 0.020 |
Why?
|
Parity | 1 | 2015 | 931 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4909 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2002 | 2662 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2017 | 2232 | 0.020 |
Why?
|
Placebos | 1 | 2015 | 1659 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8522 | 0.020 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 1464 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3447 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2002 | 3690 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2226 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3430 | 0.020 |
Why?
|
Forecasting | 2 | 2011 | 2936 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1726 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1176 | 0.020 |
Why?
|
Medical Oncology | 1 | 2000 | 2339 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2649 | 0.020 |
Why?
|
Psychotherapy | 1 | 2017 | 1648 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15802 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10611 | 0.020 |
Why?
|
Self Efficacy | 1 | 2011 | 641 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5077 | 0.020 |
Why?
|
Prognosis | 2 | 2008 | 29890 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10086 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2901 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2592 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18382 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3530 | 0.010 |
Why?
|
Prescription Drugs | 1 | 2010 | 634 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12822 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8492 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36426 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59857 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 30230 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14643 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12417 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2242 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88811 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 30192 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1777 | 0.010 |
Why?
|
Research | 1 | 2006 | 1974 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13042 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2007 | 3560 | 0.010 |
Why?
|
Software | 1 | 2008 | 4462 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10575 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13614 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2004 | 36547 | 0.000 |
Why?
|